296 related articles for article (PubMed ID: 34579695)
1. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G
BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695
[TBL] [Abstract][Full Text] [Related]
2. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
[TBL] [Abstract][Full Text] [Related]
3. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
4. High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center.
Li Y; Fang D; Bao Z; He A; Guan B; He S; Zhan Y; Gong Y; Li X; Zhou L
Onco Targets Ther; 2019; 12():2635-2648. PubMed ID: 31114222
[No Abstract] [Full Text] [Related]
5. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
[TBL] [Abstract][Full Text] [Related]
7. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
[TBL] [Abstract][Full Text] [Related]
9. Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC).
Laukhtina E; Mostafaei H; D'Andrea D; Pradere B; Quhal F; Mori K; Miura N; Schuettfort VM; Sari Motlagh R; Aydh A; Abufaraj M; Karakiewicz PI; Enikeev D; Kimura S; Shariat SF
World J Urol; 2021 Jun; 39(6):1961-1968. PubMed ID: 32808107
[TBL] [Abstract][Full Text] [Related]
10. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF
Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
Li X; Shu K; Zhou J; Yu Q; Cui S; Liu J; Zhou R; Ding D
Clin Genitourin Cancer; 2020 Feb; 18(1):11-19.e1. PubMed ID: 31787543
[TBL] [Abstract][Full Text] [Related]
13. Geriatric nutritional risk index as a prognostic factor in elderly patients with non-muscle-invasive bladder cancer: a propensity score-matched study.
Wu J; Cheng X; Yang H; Xiao S; Xu L; Zhang C; Huang W; Jiang C; Wang G
Int Urol Nephrol; 2024 May; 56(5):1627-1637. PubMed ID: 38177927
[TBL] [Abstract][Full Text] [Related]
14. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
Bezan A; Mrsic E; Krieger D; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
J Urol; 2015 Jul; 194(1):30-5. PubMed ID: 25623738
[TBL] [Abstract][Full Text] [Related]
15. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
[TBL] [Abstract][Full Text] [Related]
16. Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
Ha YS; Kim SW; Chun SY; Chung JW; Choi SH; Lee JN; Kim BS; Kim HT; Yoo ES; Kwon TG; Kim WT; Kim WJ; Kim TH
BMC Urol; 2019 Jan; 19(1):10. PubMed ID: 30678673
[TBL] [Abstract][Full Text] [Related]
17. Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.
Takenaka Y; Takemoto N; Yasui T; Yamamoto Y; Uno A; Miyabe H; Ashida N; Shimizu K; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
PLoS One; 2016; 11(10):e0164057. PubMed ID: 27732629
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
Kimura S; Soria F; D'Andrea D; Foerster B; Abufaraj M; Vartolomei MD; Karakiewicz PI; Mathieu R; Moschini M; Rink M; Egawa S; Shariat SF; Gust KM
Clin Genitourin Cancer; 2018 Dec; 16(6):e1123-e1132. PubMed ID: 30061034
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.
Kang M; Shin SJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Dis Markers; 2020; 2020():8887605. PubMed ID: 32724485
[TBL] [Abstract][Full Text] [Related]
20. Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma.
Chen SL; Li JP; Li LF; Zeng T; He X
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
